Phase I Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (GlutaPanc)
Summary
The purpose of this phase I study is to evaluate the safety and feasibility of combination therapy of gemcitabine, nab-paclitaxel, and L-glutamine in patients with advanced pancreatic cancer at Cedars-Sinai Medical Center.
General Information
NCT#: NCT04634539
Study ID: IIT2020-02-Gong-GLUTAPANC
Trial Phase: Phase I
Trial Sponsor: Jun Gong, MD
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, L-glutamine